Marks Peter Ashley

Marks Peter Ashley, Director, accounts for 2 disclosed filings worth $47.6K, all concentrated in ALTERITY THERAPEUTICS LTD (ATHE), active 2026. The record is heavily weighted toward buying, with $23.8K in purchases against $0 in sales. The largest single open-market purchase on record is $23.8K in ALTERITY THERAPEUTICS LTD. Data is sourced from official SEC Form 3, 4, and 5 filings.